Susquehanna analyst James Friedman said despite a tough macro backdrop and heightened investor concerns, Accenture had an exceptional quarter, signing a remarkable 35 contracts over $100 mln. He noted they tweaked their revenue guidance and he raised his estimates as a result. Susquehanna maintained its Positive rating and $360 price target in Accenture shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACN: